EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Benzophenone Derivatives as a New Class of Anti‐Infectives Against Acanthamoeba spp

Tomas Rimkus, Hannes Geisler iD, Taha B El-Jourani iD, Aurélien F A Moumbock iD, Matthias Schiedel iD, Stephan Reichl iD

Archiv der Pharmazie · 2026-08 · 359 (8)

DOI: 10.1002/ardp.70321 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 20.08.2026. Verfasst von Tomas Rimkus und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig, Germany. Hauptthemen laut MEDLINE: Acanthamoeba, Benzophenones, Acanthamoeba Keratitis, Antiprotozoal Agents. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rare but sight‐threatening ocular disease Acanthamoeba keratitis represents a therapeutic challenge due to its causative agents, Acanthamoeba spp ., being able to penetrate the corneal epithelium and persist in the corneal stroma as dormant and highly resistant cysts. To combat the scarcity and limitations of current treatment options, we developed a new class of anti‐infective agents against Acanthamoeba spp . based on Ro 48‐8071 ( 3 ), a known inhibitor of the human oxidosqualene cyclase (hOSC). The compound design was guided by docking studies using a homology model of the cycloartenol synthase (CAS), which is the homolog of hOSC found in Acanthamoeba spp . and essential for the parasite's steroid biosynthesis. Among the synthesized Ro 48‐8071 analogues, MSHG19 ( 4f ) evoked the most potent activity against Acanthamoeba hatchetti leading to total eradication of trophozoites and cysts at single‐digit micromolar concentrations, whereas having no effects within this concentration range on the viability of human corneal epithelial cells. With our initial set of synthesized compounds, we established a first structure–activity relationship model, which nicely aligns with the predicted binding mode of 4f to CAS. Overall, the presented findings highlight the potential of benzophenones as a new class of anti‐infectives for the treatment of Acanthamoeba keratitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcanthamoebaBenzophenonesAcanthamoeba KeratitisAntiprotozoal AgentsAmebicidesHumansStructure-Activity RelationshipDose-Response Relationship, DrugMolecular Docking SimulationMolecular StructureParasitic Sensitivity Tests

Stichwörter der Autor:innen

AcanthamoebaRo 48‐8071anti‐infectivescycloartenol synthasekeratitis

Substanzen

BenzophenonesAntiprotozoal AgentsAmebicides

Autor:innen und Institutionen

  • Institute of Pharmaceutical Technology and Biopharmaceutics, Technische Universität Braunschweig, Braunschweig, Germany.
  • Institute of Medicinal and Pharmaceutical Chemistry, Technische Universität Braunschweig, Braunschweig, Germany.
  • Institute of Pharmaceutical Sciences, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany.
  • Universität Münster, Institut für Pharmazeutische und Medizinische Chemie, Münster, Germany.
  • Center of Pharmaceutical Engineering, Technische Universität Braunschweig, Braunschweig, Germany.

ORCID-Profile: Hannes Geisler, Taha B El-Jourani, Aurélien F A Moumbock, Matthias Schiedel, Stephan Reichl

Zitieren

APA

Rimkus, T., Geisler, H., El-Jourani, T. B., Moumbock, A. F. A., Schiedel, M., & Reichl, S. (2026). Benzophenone Derivatives as a New Class of Anti‐Infectives Against Acanthamoeba spp. Archiv der Pharmazie, 359(8). https://doi.org/10.1002/ardp.70321

Vancouver

Rimkus T, Geisler H, El-Jourani TB, Moumbock AFA, Schiedel M, Reichl S. Benzophenone Derivatives as a New Class of Anti‐Infectives Against Acanthamoeba spp. Archiv der Pharmazie. 2026;359(8). doi:10.1002/ardp.70321

BibTeX
@article{Rimkus2026,
  author = {Rimkus, Tomas and Geisler, Hannes and El-Jourani, Taha B and Moumbock, Aurélien F A and Schiedel, Matthias and Reichl, Stephan},
  title = {Benzophenone Derivatives as a New Class of Anti‐Infectives Against Acanthamoeba spp},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {8},
  doi = {10.1002/ardp.70321}
}
Kostenlos starten →